Implementation of a novel molecular trojan horse-like technology as a possible future strategy in non-viral gene therapy to combat hereditary forms of cancer
nanoparticles with tumour-specific receptors on the surface of the tumour cells triggers a Trojan horse-like mechanism tricking the tumour cells to act against themselves by welcoming the anticancer ... phase III…

